Search - tctmd.com

Displaying 621 - 640 of 1361

Sort: Relevancy | Date

Incidental Thrombi on Device Leads Common, but Seemingly Innocuous

News Daily News

Incidental Thrombi on Device Leads Common, but Seemingly Innocuous

February 28, 2019

DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight

News Daily News

DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight

February 25, 2019

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

February 19, 2019

How to select a NOAC: a simple guide for the busy interventionist

Presentation JIM 2019

How to select a NOAC: a simple guide for the busy interventionist

Presenter: Roberta Rossini

February 14, 2019

Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects

News Conference News ISC 2019

Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects

February 13, 2019

Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients

News Conference News ISC 2019

Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients

February 07, 2019

Acute PE Algorithm in the Works to Guide Clinicians’ Complex Decision-making

News Conference News ISET 2019

Acute PE Algorithm in the Works to Guide Clinicians’ Complex Decision-making

February 05, 2019

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

News Daily News

AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline

Michael O'Riordan

January 29, 2019

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

News Daily News

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

January 29, 2019

What Are the Current Recommendations for “Optimal Medical Therapy”

Presentation LINC 2019

What Are the Current Recommendations for “Optimal Medical Therapy”

Presenter: Daniella Kadian-Dodov

January 25, 2019

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

News Daily News

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

January 22, 2019

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

January 21, 2019

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

January 09, 2019

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

Presentation

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

January 09, 2019

Stroke Risk Increases Over Time in Many Patients With A-fib

News Daily News

Stroke Risk Increases Over Time in Many Patients With A-fib

January 08, 2019

Quality of Anticoagulation Therapy Lower in Black Patients With A-fib

News Daily News

Quality of Anticoagulation Therapy Lower in Black Patients With A-fib

December 03, 2018

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

Complications Following TAVR Are Going Down, US Data Show

News Conference News AHA 2018

Complications Following TAVR Are Going Down, US Data Show

Yael L. Maxwell

November 20, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

November 11, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.